Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Recent developments in the U.S. highlight growing concerns over Chinese biotech companies' activities. WuXi AppTec opposes a U.S. bill restricting Chinese pharma groups, while the U.S. targets four Chinese biotech firms for national security reasons. Legal experts discuss the implications of proposed legislation on U.S. companies' contracts with Chinese biotech firms.
The BIOSECURE Act: Too Early to Call? https://t.co/nJXL2kBAJ1 | by @fenwickwest
Washington’s My Health My Data Act – A Roadmap for Compliance https://t.co/XcLOOlvwUo | by @fenwickwest
The Countdown to Complete Your Consumer Health Data Privacy Policy Under the Washington My Health My Data Act https://t.co/d9GrMNJIhi #health #dataprivacy #privacypolicy @KLGates https://t.co/XQu7UeSDHy
